|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
5 December 2022 |
|
Main ID: |
NCT02217267 |
|
Date of registration:
|
13/08/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain
|
|
Scientific title:
|
Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain : A Pilot Study |
|
Date of first enrolment:
|
August 1, 2014 |
|
Target sample size:
|
29 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02217267 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
|
Phase:
|
Phase 3
|
|
|
Countries of recruitment
|
|
Thailand
| | | | | | | |
|
Contacts
|
|
Name:
|
Suratsawadee Wangnamthip, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Mahidol University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Peripheral neuropathic pain from peripheral nerve injury within 6 months after injury
- Well understand to Thai language in writing or listening
Exclusion Criteria:
- Underlying Heart disease or Arrhythmia
- Allergy to lidocaine, Gabapentin, Carbamazepine, tramadol
- History of epilepsy
- History of lidocaine used
- Underlying Psychiatric disease
- History of drug abuse
- Pregnancy and nursing
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Peripheral Neuropathy
|
|
Intervention(s)
|
|
Drug: Placebo
|
|
Drug: Lidocaine
|
|
Primary Outcome(s)
|
|
Pain intensity
[Time Frame: at 3 months after serial lidocaine infusion]
|
|
Secondary Outcome(s)
|
|
Quality of life using Utility score
[Time Frame: at 3 month after serial lidocaine infusion]
|
|
Secondary ID(s)
|
|
SI140/2014
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|